PCOS Renamed to PMOS: Impact on Indian Corporate Wellness & HR ROI

Polycystic Ovary Syndrome (PCOS) is officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS). Discover what this landmark medical shift means for corporate wellness, employee productivity, and enterprise health strategy in India. The Landmark Shift from PCOS...

GLP-1 Weight Loss Drugs in Indian Corporate Wellness: Cost vs. Employee Health ROI

The GLP-1 Revolution in Indian Corporate Wellness: Navigating Rising Costs, Employee Health, and the Shift to Preventive Healthcare 1. Introduction: The New Frontier of Corporate Health Indian corporate boardrooms face an unprecedented workforce crisis. This challenge...